Today: 7 February 2026
Subscribe

LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

Lockheed Martin (NYSE: LMT) heads into Tuesday’s session under pressure, even as its fundamentals look solid on paper. As of late Monday trading, Lockheed Martin shares were changing hands around $451, down roughly 2.1% from Friday’s close near $460.78, extending a four‑day losing streak. StockInvest Despite that slide, the defense giant just delivered strong third‑quarter 2025 results, raised its full‑year outlook, reported a record $179 billion order backlog, and approved a 5% dividend hike for the fourth quarter. Media – Lockheed Martin+2Reuters+2 Below is a detailed look at where LMT stock stands today, what’s driving sentiment, and what investors will
25 November 2025
·
Procter & Gamble (NYSE: PG) Stock Today – November 25, 2025: Price, Analyst Upgrade, and New Brand Launches

Procter & Gamble (NYSE: PG) Stock Today – November 25, 2025: Price, Analyst Upgrade, and New Brand Launches

The Procter & Gamble Company (NYSE: PG) enters Tuesday, November 25, 2025, under pressure in the stock market but with a surprisingly upbeat backdrop of analyst upgrades, brand innovation, and bullish options activity. After a sharp drop in Monday’s session, PG last traded around $146.98, about 2.6% below its prior close near $150.92, with an intraday range roughly between $146.54 and $150.41 and heavy volume of about 13.8 million shares. StockAnalysis+1 Pre‑market trading early Tuesday shows PG in the high‑$140s, modestly above Monday’s close, suggesting a small rebound of roughly 1% as investors digest the sell‑off rather than panic‑dump the
25 November 2025
Chevron (CVX) Stock Today, November 25, 2025: Price, Venezuela Feedstock Deal and Dividend Power in a Weak Oil Market

Chevron (CVX) Stock Today, November 25, 2025: Price, Venezuela Feedstock Deal and Dividend Power in a Weak Oil Market

Published: November 25, 2025 – informational, not investment advice. Key takeaways for Chevron stock today (25 November 2025) Below, we break down what all of this means for Chevron stock on Tuesday, November 25, 2025. Chevron (CVX) stock price today: still stuck near the $150 line As of early trading on Tuesday, Chevron shares are changing hands near $149.75, with intraday moves so far confined to a relatively tight band around that level. Market data show a recent day’s high and low in the $147.7–$150.5 zone and only about a 0.2% decline versus the previous close, meaning there’s no dramatic
25 November 2025
···
AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

New York — November 25, 2025 — Axsome Therapeutics (NASDAQ: AXSM) heads into Tuesday’s session trading just below fresh record highs, powered by blockbuster growth from its depression drug Auvelity, the launch of migraine pill Symbravo, and a rapidly expanding neuroscience pipeline. Shares closed on Monday, November 24, at $151.20, up 1.2% on the day and modestly higher in after-hours trading around $152. That puts AXSM near the top of its 52‑week range of $75.56 to $151.39, valuing the CNS-focused biotech at roughly $7.6 billion. StockAnalysis+1 Over the past year, Axsome’s stock has climbed more than 50% (around 54% on
25 November 2025
ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Key Takeaways ALT stock price today: how Altimmune is trading on November 25, 2025 Altimmune Inc. (NASDAQ: ALT) continues its November rebound. As of early trading on Tuesday, November 25, ALT is changing hands around $5.1 per share, roughly flat to slightly higher versus Monday’s close. Intraday ranges have been tight so far, with trading largely clustered between about $4.8 and $5.2 per share. INDmoney On Monday, November 24, ALT: According to short‑term technical data, ALT has risen in 6 of the last 10 trading days and is up almost 20% over the past two weeks, as traders reposition ahead
25 November 2025
··
Philip Morris International (PM) Stock Today, November 25, 2025: Dividend Hike, Debt Moves and Billionaire Rotations Shape the Outlook

Philip Morris International (PM) Stock Today, November 25, 2025: Dividend Hike, Debt Moves and Billionaire Rotations Shape the Outlook

Philip Morris International Inc. (NYSE: PM) enters Tuesday’s session under pressure after a sharp pullback, even as fundamentals, dividends and its smoke‑free pivot remain in focus. PM stock at a glance on 25 November 2025 Against this backdrop, several fresh headlines and recent corporate moves are steering sentiment around Philip Morris International on November 25, 2025. How Philip Morris stock is trading into Tuesday Monday’s nearly 3% slide left PM near $151, extending a short‑term downtrend that has seen the stock ease by just over 2% in the past two weeks and modestly negative over the last month. StockInvest+2StockInvest+2 Despite
25 November 2025
·
Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Frankfurt am Main – 25 November 2025 After one of the sharpest pullbacks in its multi‑year rally, German defence group Rheinmetall AG (Xetra: RHM, ticker: RHM.DE) enters Tuesday’s session under close watch. The stock is trading almost 20% below its early‑November peak, even as the company reports record order books, confirms strong 2025 guidance and lays out an ultra‑ambitious 2030 roadmap. Investing.com+2Yahoo Finance+2 Below is a structured look at where RHM.DE stands today, what’s been driving the latest volatility and the key catalysts investors are likely to focus on over the coming days and months. Rheinmetall share price: a sharp
25 November 2025
··
Intuit Stock Today (INTU) on November 25, 2025: AI‑Fueled Rally, OpenAI Deal and New Open Banking Push

Intuit Stock Today (INTU) on November 25, 2025: AI‑Fueled Rally, OpenAI Deal and New Open Banking Push

On Tuesday, November 25, 2025, Intuit Inc. (NASDAQ: INTU) heads into the U.S. trading session riding a powerful mix of earnings momentum, fresh AI partnerships and brand‑new open banking news out of Australia. Here’s a detailed look at where the stock stands today, what’s driving sentiment, and the key developments investors should be watching. INTU stock price snapshot for November 25, 2025 As of Monday’s close on November 24, ahead of today’s session, Intuit shares were trading around $653 per share, with an after‑hours quote near $653.18. That gives the company a market capitalization of roughly $182 billion.StockAnalysis Over the
25 November 2025
··
Uber Stock Today (November 25, 2025): Getir Food Deal, Gig Worker Pay Breakthrough and Holiday Push Shape NYSE: UBER

Uber Stock Today (November 25, 2025): Getir Food Deal, Gig Worker Pay Breakthrough and Holiday Push Shape NYSE: UBER

Uber Technologies, Inc. (NYSE: UBER) stock is trading slightly lower today as investors weigh a busy news day: a proposed acquisition of Getir’s food delivery business in Türkiye, a landmark minimum-pay deal for Uber Eats riders in Australia, fresh Uber One membership perks, and new delivery milestones in key markets. Uber share price today: UBER edges lower but stays near 2025 highs As of the latest available data on November 25, 2025, Uber shares are trading around $83.7, down roughly 0.3% on the session. The stock has moved between about $83.0 and $84.8 intraday, with volume close to 25 million
25 November 2025
Comfort Systems USA (FIX) Stock on November 25, 2025: CEO Share‑Sale Filing After a 123% YTD Rally

Comfort Systems USA (FIX) Stock on November 25, 2025: CEO Share‑Sale Filing After a 123% YTD Rally

Comfort Systems USA, Inc. (NYSE: FIX) heads into Tuesday, November 25, 2025, near record territory after a spectacular year in which the stock has gained roughly 123% year‑to‑date, closing Monday at $945.07 with a 2025 high above $1,020 and a 52‑week low of $276.44. At that level the company is valued at about $33 billion and trades at roughly 40x trailing earnings, with a modest dividend yield of about 0.25%. MarketBeat+1 While there is no new earnings release or major contract announcement dated November 25, the stock is in focus today because of a fresh insider share‑sale filing from the
25 November 2025
SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Shares of Sarepta Therapeutics (NASDAQ: SRPT) head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its experimental RNA therapy SRP‑1003 and weigh it against fresh FDA warnings and trial setbacks tied to its gene therapy Elevidys. SRPT stock today at a glance As of Monday’s close (November 24, 2025), here’s where SRPT stands: In other words, Monday’s bounce was meaningful, but comes after a brutal collapse from triple‑digit levels earlier in 2025. New SRP‑1003 data: a rare bright spot for SRPT stock On Monday, Sarepta released a progress update for
25 November 2025
··
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. (NASDAQ: RUM) heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto giant Tether and a transformational AI infrastructure deal with Germany’s Northern Data. As of Monday, November 24, RUM closed at $6.51, up about 14.4% on the day, after trading between $5.92 and $6.57 on unusually heavy volume of roughly 7.2 million shares, well above recent averages. FinancialContent That follows a 7% gain on Friday, lifting the stock more than 22% over the last two sessions and putting it back near the upper end of
25 November 2025
···
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital, Inc. (NASDAQ: NUAI) heads into Tuesday’s session on the back of a sharp rally and a major expansion update for its flagship Texas AI data center project. As of Monday’s close on November 24, NUAI finished at $4.40, up about 15.8% on the day, with roughly 8.6 million shares traded on the Nasdaq. StockAnalysis The stock remains deeply volatile and, despite the latest bounce, is still down more than 60% over the past 12 months. StockAnalysis This move followed fresh news that the company’s joint venture has locked in more land for its Texas AI
25 November 2025
···
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s Corporation (NYSE: KSS) heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday shopping season ramping up—all against a backdrop of heavy short interest and lingering doubts about the department‑store model. As of early Tuesday, KSS is trading around $15.70 per share, giving Kohl’s a market value of roughly $1.8 billion and leaving the stock in the lower half of its 52‑week range of about $6.04 to $21.39. GuruFocus+1 Key Takeaways for KSS Stock on November 25, 2025 KSS Stock Price Today: Volatile but Off the Lows
25 November 2025
·
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still roughly 24% below their early‑November high near $168. StockAnalysis+1 Over the past month, the stock has dropped almost 20%, even after Monday’s rebound, while it remains up around 10% year‑to‑date and down about 12% over the last 12 months. MarketBeat+1 That combination of strong year‑to‑date gains, a sharp recent sell‑off, and a big AI narrative makes Dell one of the
25 November 2025
···
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
·
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and above its original target. Viking Therapeutics InvestorRoom As of yesterday’s close (Monday, November 24), VKTX changed hands at $34.65, implying a market capitalization of roughly $3.9 billion. Stock Titan Shares sit well below their 52‑week high of $56.25, but far above the 52‑week low of $18.92, underscoring how volatile the weight‑loss drug trade has become. Investing.com+1 With Phase 3 trials
25 November 2025
··
Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Date: November 25, 2025 Johnson & Johnson (NYSE: JNJ) heads into Tuesday’s session at or near record highs, riding a wave of bullish options activity, a key ex‑dividend date today and a string of growth-focused pipeline moves in cancer and neuroscience. As of the latest completed trading session on Monday, November 24, JNJ was trading around $206 per share, close to its 12‑month high just under $207, with a 12‑month low near $141, a price/earnings ratio around 20 and a dividend yield in the ballpark of 2.5%–2.6%.MarketBeat+1 The stock is up more than 7% since the first trading day of
25 November 2025
··
Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

As markets head into the Tuesday, November 25, 2025 session, Coca-Cola Company (The) stock (NYSE: KO) is trading in classic “steady blue‑chip” fashion: modest price moves, strong dividend support, and quietly improving fundamentals. As of the close on Monday, November 24, KO finished at $72.59, down about 0.5% on the day but still up roughly 13–14% over the last 12 months and trading well above both its 50‑day and 200‑day moving averages.StockAnalysis Over the past year, the stock has moved in a range of roughly $60–$74, leaving it nearer the upper half of that band as investors position for year‑end.MarketBeat+1
25 November 2025
DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest in compliance-focused AI.Simply Wall St+1 Now, heading into Tuesday, November 25, 2025, DGNX is back in the spotlight after the company signed a non‑binding memorandum of understanding (MOU) to acquire The Remedy Project, a specialist in human-rights risk and worker-centered remediation for global supply chains.ir.diginex.com+2Nasdaq+2 Below is a detailed look at where DGNX stock stands today, what’s driving the latest
25 November 2025
·
1 … 1,236 1,237 1,238 1,239 1,240 … 1,632

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
New York, Feb 7, 2026, 11:05 EST — Market closed. Costco Wholesale Corp (COST.O) closed Friday up 1.2% at $1,001.16, clawing back above the $1,000 mark into the weekend. The stock ranged from $982.30 to $1,001.20 and traded about 2.36 million shares, with U.S. markets shut on Saturday. The move matters because Costco has become a quick read on the steadier end of U.S. consumer spending, and it is landing right as investors try to sort out whether rates are headed down again — and what that does to big, expensive retail names. A consumer snapshot on Friday did not
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop